NDC 51672-5275 - Citalopram Hydrobromide

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 51672-5275
Package NDCs from labels: 51672-5275-6, 51672-5275-1, 51672-5275-0
Manufacturer: Taro Pharmaceuticals U.S.A., Inc.
Effective date: 2009-03-16
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
Citalopram Hydrobromide Tablets	Taro Pharmaceuticals U.S.A., Inc.	2009-03-16	HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
51672-5275-0	Citalopram Hydrobromide	10 in 1 CARTON	TABLET, FILM COATED	10	1
51672-5275-0	Citalopram Hydrobromide	10 in 1 BLISTER PACK	TABLET, FILM COATED	10	1
51672-5275-1	Citalopram Hydrobromide	100 in 1 BOTTLE	TABLET, FILM COATED	100	1
51672-5275-6	Citalopram Hydrobromide	30 in 1 BOTTLE	TABLET, FILM COATED	30	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
51672-5275	CITALOPRAM HYDROBROMIDE TABLET, FILM COATED [TARO PHARMACEUTICALS U.S.A., INC.]	1	4 package rows	20090630_C0FCB440-2C9F-4841-B164-5AB7168D81D9.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
Citalopram Hydrobromide	ACTIVE INGREDIENT	I1E9D14F36	CITALOPRAM HYDROBROMIDE TABLET, FILM COATED [TARO PHARMACEUTICALS U.S.A., INC.]	1
Citalopram	ACTIVE MOIETY	0DHU5B8D6V	CITALOPRAM HYDROBROMIDE TABLET, FILM COATED [TARO PHARMACEUTICALS U.S.A., INC.]	1
cellulose, microcrystalline	INACTIVE INGREDIENT	OP1R32D61U	CITALOPRAM HYDROBROMIDE TABLET, FILM COATED [TARO PHARMACEUTICALS U.S.A., INC.]	1
hypromellose	INACTIVE INGREDIENT	3NXW29V3WO	CITALOPRAM HYDROBROMIDE TABLET, FILM COATED [TARO PHARMACEUTICALS U.S.A., INC.]	1
magnesium stearate	INACTIVE INGREDIENT	70097M6I30	CITALOPRAM HYDROBROMIDE TABLET, FILM COATED [TARO PHARMACEUTICALS U.S.A., INC.]	1
mannitol	INACTIVE INGREDIENT	3OWL53L36A	CITALOPRAM HYDROBROMIDE TABLET, FILM COATED [TARO PHARMACEUTICALS U.S.A., INC.]	1
polyethylene glycol	INACTIVE INGREDIENT	3WJQ0SDW1A	CITALOPRAM HYDROBROMIDE TABLET, FILM COATED [TARO PHARMACEUTICALS U.S.A., INC.]	1
silicon dioxide	INACTIVE INGREDIENT	ETJ7Z6XBU4	CITALOPRAM HYDROBROMIDE TABLET, FILM COATED [TARO PHARMACEUTICALS U.S.A., INC.]	1
titanium dioxide	INACTIVE INGREDIENT	15FIX9V2JP	CITALOPRAM HYDROBROMIDE TABLET, FILM COATED [TARO PHARMACEUTICALS U.S.A., INC.]	1

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 5 of 5 · 82 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
CITALOPRAM HYDROBROMIDE	CITALOPRAM	Aphena Pharma Solutions - Tennessee, LLC	d05f4e71-95f3-4f22-8b01-b21e5c19e0f2	2018-07-16	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 200371
079AEBC4-1BA7-1BDE-1C14-4C502938D410			C0FCB440-2C9F-4841-B164-5AB7168D81D9	2009-03-16	Boxed warning, Warnings, Adverse reactions	Exact identifier spl id: 079AEBC4-1BA7-1BDE-1C14-4C502938D410 spl set id: C0FCB440-2C9F-4841-B164-5AB7168D81D9

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.